Wednesday, January 21, 2015

10 Best Cheapest Stocks To Own Right Now

Mexico�� IPC index rose the most among major stock benchmarks in the Americas and Europe today, capping its biggest weekly advance since 2009 after plunging on June 20 to a one-year low.

The IPC rose 2.5 percent to 40,623.30 at the close in Mexico City. The index gained 6.8 percent on the week, the most since July 2009. Steelmaker Industrias CH SAB (ICHB) was the biggest gainer today, while homebuilders Desarrolladora Homex SAB, Urbi Desarrollos Urbanos SAB, and Corp. Geo SAB were the week�� best performers.

Global stocks had plunged earlier in June amid speculation that the U.S. Federal Reserve is moving to taper monetary stimulus that has pushed investors to put money into higher-yielding emerging markets. Last week the index fell to 14.9 times analysts��earnings estimates, the cheapest since June 2012.

��aluations reached a very low level,��Luis Rodriguez, the director of research at Casa de Bolsa Finamex SAB in Guadalajara, Mexico, said by phone. ��ll emerging markets had a good week, and there are some good fundamentals in the Mexican economy that have been recognized by the market, so the bounce was larger,��

Hot Industrial Disributor Companies To Own For 2015: Barry Callebaut AG (BARN)

Barry Callebaut AG is a Switzerland-based producer of cocoa, chocolate and confectionery products. The Company�� manufacturing process involves all stages of the cocoa and chocolate value chain from the sourcing of raw materials to the delivery of the finished products. The Company operates three geographical segments, including Europe, Americas and Asia-Pacific, as well as its business segment Global Sourcing & Cocoa. The Global Sourcing & Cocoa business segment is responsible for the procurement of ingredients for chocolate production, including mainly cocoa, as well as sugar, dairy and nuts as common ingredients, as well as the Company's cocoa processing business. The Company serves the food industry, from industrial food manufacturers to professional or artisanal users of chocolate. The Company operates more than 50 chocolate and cocoa factories, and is present in over 30 countries. Advisors' Opinion:
  • [By Sofia Horta e Costa]

    Elan Corp. jumped 8.4 percent in Dublin after authorizing the process of its sale. Hochtief AG gained the most in four months after the German builder said it will buy as much as 260 million euros ($346 million) of its own shares. Michelin & Cie, Europe�� largest tiremaker, added 4.7 percent after data on its website showed tire demand surged in Brazil last month. Barry Callebaut AG (BARN) lost 3.4 percent after the maker of bulk chocolate sold about $302 million of new shares.

10 Best Cheapest Stocks To Own Right Now: Skyline Corporation(SKY)

Skyline Corporation and its subsidiaries engage in designing, producing, and marketing manufactured houses, modular homes, and towable recreational vehicles to independent dealers and manufactured housing communities in the United States and Canada. The company?s manufactured homes include two to four bedrooms, kitchen, dining area, living room, one or two bathrooms, kitchen appliances, and central heating and cooling, as well as exterior dormers and windows, interior or exterior accent columns, fireplaces, and whirlpool tubs. Its towable recreational vehicles comprise travel trailers and fifth wheels offered under the Aljo, Bobcat, Koala, Layton, Mountain View, Nomad, Texan, Wagoneer, Walkabout, and Weekender brands; and park models under the Cedar Cove, Cutlass, Cutlass Elite, Deerfield, Forest Brook, Shore Park Homes, and Vacation Villa brands, which consists of sleeping, kitchen, dining, and bath areas. The company markets its manufactured and modular housing to subur ban and rural areas of the continental United States and Canada. Skyline Corporation markets its recreational vehicles to vacationing families, traveling retired couples, and sports enthusiasts pursuing four-season hobbies. The company was founded in 1951 and is headquartered in Elkhart, Indiana.

Advisors' Opinion:
  • [By John Udovich]

    The CEO of recreation vehicle (RV) stock Winnebago Industries, Inc (NYSE: WGO) recently appeared on CNBC to say that the economy is improving for RV makers, meaning its time to take a closer look at the stock plus take a look at the performance of other small cap RV stocks like Drew Industries, Inc (NYSE: DW), Skyline Corporation (NYSEMKT: SKY) and Thor Industries, Inc (NYSE: THO).

10 Best Cheapest Stocks To Own Right Now: Garmin Ltd.(GRMN)

Garmin Ltd., together with its subsidiaries, designs, develops, manufactures, and markets global positioning system (GPS) enabled products and other navigation, communication, and information products for the automotive/mobile, outdoor, fitness, marine, and general aviation markets worldwide. The company offers a range of automotive navigation products, and various products and applications designed for the mobile GPS market; GPS enabled handheld products for hunters, hikers, geocachers, outdoors enthusiasts, cyclists, and golfers; dog tracking systems; tracker systems; and training assistants for athletes. It also provides handhelds, network products and multifunction displays, fixed-mount GPS/chartplotter products, instruments, fish finders, radars, autopilots, VHF radios, marine networking products, and sounder products. In addition, the company offers GPS-enabled navigation, VHF communications transmitters/receivers, multi-function displays, electronic flight instrumen tation systems, automatic flight control systems, traffic advisory systems and traffic collision avoidance systems, terrain awareness and warning systems, instrument landing system receivers, surveillance products, audio panels, and cockpit datalink systems. The company?s sells its products through a network of independent dealers and distributors, as well as through original equipment manufacturers. Garmin Ltd. was founded in 1990 and is based in Schaffhausen, Switzerland.

Advisors' Opinion:
  • [By Rich Bieglmeier]

    [Related -Garmin Ltd. (GRMN) Q4 Earnings Preview: Too Unpredictable to Trade]

    Garmin is a provider of navigation, communication and information devices and applications, which are enabled by global positioning system (GPS) technology. Garmin designs, develops, manufactures and markets a diverse family of hand-held, portable and fixed-mount GPS-enabled products and other navigation, communications and information products for the automotive/mobile, outdoor, fitness, marine, and general aviation markets. Garmin has four segments: Automotive/Mobile, Aviation, Marine, Outdoor and Fitness.

  • [By WWW.DAILYFINANCE.COM]

    www.pivotalliving.com It's about to get a lot cheaper to track your fitness activity, calories burned and sleep patterns. The Life Tracker 1 will begin shipping later this year, costing just $12 a year for the wristband hardware and access to the reporting software app. Pivotal Living is the company behind the low-cost entry into the crowded and competitive fitness tracking niche. The Seattle-based upstart is helmed by a former Microsoft (MSFT) employee, but the real head-turning aspect of the Life Tracker 1's debut is its price. Today's most popular fitness bracelets start at $60, with more advanced models selling north of $100. You're going to generate plenty of buzz if you hit the market with a wearable device given away with the $12 annual app subscription. Catching Up in a Hurry The fitness tracker market has been dominated by Fitbit and Jawbone for years. Nike (NKE) tried to give it a go with its Nike+ FuelBand. The $149 fitness bracelet got off to a strong start two years ago with its high-tech device that uses a three-axis accelerometer to track movements using a proprietary NikeFuel metric of measurement. However, it failed to gain traction, and Nike went on to lay off the majority of the FuelBand's hardware team in April, discontinuing a slimmer model that was supposed to hit the market this year. Nike is the undisputed champ of athletic footwear and apparel, but sometimes a killer brand isn't enough. We've seen that with Samsung (SSNLF) and Garmin (GRMN) with their recent push into wearables, and in a few weeks, we'll see Apple (AAPL) give it a shot with its Apple Watch. Apple is gunning for the high end of the wearables market with a smartwatch starting at $349. That device will of course, track fitness activity, but its major selling points are how it plays nice with smartphones to serve up calls, notifications, text messages and even select app interactions. Big tech sees big money in grabbing you by the wrist, but that trend also represent

  • [By Tom Rojas and Maria Armental var popups = dojo.query(".socialByline .popC"); ]

    Garmin Ltd.(GRMN) said revenue in the third-quarter increased 9.7% on a 43% sales jump in its fitness segment. The results topped analyst expectations, leading the company to again lift its outlook for the year.

  • [By Laura Brodbeck]

    Wednesday

    Earnings Expected From: Marriott International (NYSE: MAR), MetLife, Inc. (NYSE: MET), Facebook, Inc. (NASDAQ: FB), Garmin Ltd (NASDAQ: GRMN), Ryland Group, Inc. (NYSE: RYL) Economic Releases Expected: British consumer confidence, New Zealand Interest rate decision, US FOMC meeting announcement, German CPI, US GPD, US core CPI, US nonfarm employment change

    Thursday

10 Best Cheapest Stocks To Own Right Now: TearLab Corporation(TEAR)

TearLab Corporation operates as an ophthalmic device company. It engages in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company?s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab disposable and the TearLab pen, as well as provides a quantitative reading for the operator. TearLab Corporation markets its system through a network of distributors in North America, Europe, and Asia. The company, formerly known as OccuLogix, Inc., was founded in 1996 and is headquart ered in San Diego, California.

Advisors' Opinion:
  • [By Roberto Pedone]

    One potential earnings short-squeeze candidate is in-vitro diagnostic player TearLab (TEAR), which is set to release numbers on Tuesday after the market close. Wall Street analysts, on average, expect TearLab to report revenue of $3.51 million on a loss of 13 cents per share.

    This company has managed to top Wall Street estimates two times over the last four quarters, which is a bullish earnings trend. If TearLab can delve another beat, then shares could be setting up for a large move higher.

    The current short interest as a percentage of the float for TearLab is extremely high at 37.1%. That means that out of the 25.54 million shares in the tradable float, 8.59 million shares are sold short by the bears. This is a huge short interest on a stock with a very low tradable float. If the bulls get the earnings news they're looking for, then shares of TEAR could easily explode higher post-earnings as the bears jump to cover some of their bets.

    From a technical perspective, TEAR is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last six months, with shares moving higher from its low of $5.26 to its recent high of $15.18 a share. During that uptrend, shares of TEAR have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of TEAR within range of triggering a major breakout trade post-earnings.

    If you're bullish on TEAR, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $14.28 to its 52-week high at $15.18 a share with high volume. Look for volume on that move that registers near or above its three-month average action of 942,598 shares. If that breakout hits, then TEAR will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside

  • [By Seth Jayson]

    TearLab (Nasdaq: TEAR  ) reported earnings on May 13. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 31 (Q1), TearLab beat expectations on revenues and exceeded expectations on earnings per share.

10 Best Cheapest Stocks To Own Right Now: Dialog Semiconductor PLC (DLG)

Dialog Semiconductor Plc creates integrated, mixed signal integrated circuits (ICs), optimized for personal portable, short-range wireless, lighting, display and automotive applications. The Company operates in three business segments: Mobile Systems, Automotive and Industrial, and Connectivity. The Mobile Systems segment includes its power management and audio chips especially designed to meet the needs of the wireless systems markets and a range of advanced driver technologies for low power display applications - from Passive Matrix Organic Light Emitting Diodes (PMOLEDs), to electronic paper and Micro Electro-Mechanical Systems (MEMS) displays. The Automotive and Industrial segment consists of products, which address the safety, management and control of electronic systems in cars and for industrial applications. The Connectivity segment includes activities, such as short-range wireless, digital cordless and voice over Internet protocol (VoIP) technology. Advisors' Opinion:
  • [By Jonathan Morgan]

    Direct Line (DLG) dropped 2.5 percent to 212.6 pence. RBS sold 300 million shares at 210 pence apiece in its third sale of a stake in the insurance company, according to a statement. The bank, which is majority owned by the U.K. government, reduced its holding in Direct Line by 20 percent to 28.5 percent. RBS slipped 1.3 percent to 364.1 pence.

10 Best Cheapest Stocks To Own Right Now: Prima BioMed Ltd (PBMD)

Prima BioMed Ltd is a biotechnology company is engaged in the development and commercialization of medical therapies with a focus on oncology. Its product candidates in development include Cvac, an autologous dendritic cell vaccine for ovarian cancer, monoclonal antibodies for multiple tumour types, and an oral formulation for the human papilloma virus (HPV), vaccine. Its product candidate Cvac is a dendritic cell therapy, for which it is conducting a Phase IIb trial for the treatment of ovarian cancer. Cvac is designed to target the tumour antigen mucin-1, which is expressed at high levels on different tumour types. It also has two preclinical product development programs. In May 2011, Prima BioMed GmbH, a 100 % owned subsidiary of Prima BioMed Ltd, was incorporated in Germany. In May 2011, Prima BioMed Middle East FZLLC, a 100 % owned subsidiary of Prima BioMed Ltd, was incorporated in the United Arab Emirates. Advisors' Opinion:
  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) shares dipped 38.59% to touch a new 52-week low of $1.44 after the company reported top-line analysis of CVac Phase 2 trial.

  • [By Bryan Murphy]

    Were it the first time, or even the second time, it happened, it might be dismissible. A third time though? As they say, the third time is the charm. If the old saying applies in the worlds of small cap stocks (and it usually does), then Prima Biomed Ltd. (NASDAQ:PBMD) just kick-started what could be a trade-worthy rally.

  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) dropped 38.17% to $1.45 after the company reported top-line analysis of CVac Phase 2 trial.

    Tower Group International (NASDAQ: TWGP) plummeted 24.31% to $10.49. Tower Group announced its plans to release its Q2 results during the week of October 7, 2013. FBR Capital downgraded the stock from Outperform to Market Perform.

10 Best Cheapest Stocks To Own Right Now: Concord Medical Services Holdings Limited (CCM)

Concord Medical Services Holdings Limited, together with its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People�s Republic of China. The company�s services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, proton beam therapy, diagnostic imaging, and other treatment and diagnostic modalities. It offers clinical support services; develops treatment protocols for doctors; and organizes joint diagnosis between doctors in its network and clinical research. The company also operates a specialty cancer hospital, as well as leases medical and diagnostic equipment. As of March 31, 2011, it operated a network of 121 centers with 68 hospital partners that cover 46 cities and 24 provinces, and administrative regions in China. The company was founded in 1996 and is headquartered in Beijing, the People�s Republic of China.

Advisors' Opinion:
  • [By John Udovich]

    China is set to ease the one child policy, something that could benefit Chinese stocks in general but be especially beneficial to insurance stocks like China Life Insurance Company Ltd (NYSE: LFC) and CNinsure Inc (NASDAQ: CISG) plus health care stocks like Mindray Medical International Ltd�(NYSE: MR) and Concord Medical Services Hldg Ltd (NYSE: CCM). First, let�� be clear that China is NOT abolishing the one child policy as the changes will merely�allow married couples to have two children if one spouse is an only child plus it will be up to China�� 34 province-level administrations to revise�their laws and put the new policy into effect. Moreover, China�� family-planning bureaucracy employs more than 500,000 full-time workers and six million part-time workers all the way down to the village level to�collect billions of dollars in fines and these bureaucrats have fought for years against policy changes���meaning they could throw up roadblocks if not placated. With that said, the insurance and health care sectors are two sectors with publicly Chinese stocks that look set to�take advantage of the coming changes.

No comments:

Post a Comment